Allosteric Targeting of the Dopamine D2 Receptor: A novel Approach for the Treatment of Parkinson's Disease

  • Lane, Robert (Primary Chief Investigator (PCI))
  • Capuano, Ben (Chief Investigator (CI))
  • Javitch, Jonathan (Chief Investigator (CI))
  • Shi, Lei (Chief Investigator (CI))
  • van den Buuse, Maarten (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/16 → 31/12/18

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$234,822.00
  • National Health and Medical Research Council (NHMRC) (Australia): A$234,822.00